This approach showed more consistent success using second-generation radioligands, with higher TSPO PET brain signal found in multiple sclerosis, ALS, mild cognitive impairment, and AD compared to controls [30,101,102,103,104,105,106,107,108,109,110]. Here, TSPO is linked to Alzheimer disease.